A new data-driven study tracked and analyzed gout-related healthcare costs for more than three years, determining the financial burden of flares and the possible benefit of proper flare management…

A new data-driven study tracked and analyzed gout-related healthcare costs for more than three years, determining the financial burden of flares and the possible benefit of proper flare management…
David Douglas |
NEW YORK (Reuters Health)—Serum biomarkers can discriminate between Crohn’s disease (CD) and ulcerative colitis (UC), according to Danish and Dutch researchers. “The biomarker assays measure neo-epitopes, which are fragments of extracellular matrix protein degradation,” Joachim Høg Mortensen, a PhD student at Nordic Bioscience in Herlev, Denmark, told Reuters Health by email. “These neo-epitopes are increasingly…
Ben Hirschler |
LONDON (Reuters)—The Chinese market is getting tougher for Western pharmaceutical companies as Beijing bears down on a rising healthcare bill and prices come under pressure. The country, which has overtaken Japan as the world’s second largest market for prescription medicines after the U.S., has drawn major investment from global drugmakers in recent years — but…
Rob Goodier |
NEW YORK (Reuters Health)—Two classes of inflammatory diseases, uveitis and psoriatic disease, appear linked, as a diagnosis of one increases the risk of developing the other, new research has found. A study of Danish patient registries found nearly triple the rate of uveitis among patients with psoriatic arthritis compared to the general population, and double…
Caroline Humer |
NEW YORK (Reuters)—U.S. hospitals urged antitrust regulators this week to consider whether health insurer Anthem Inc’s planned acquisition of rival Cigna Corp would boost healthcare costs. In a letter to the Department of Justice, the hospital industry’s largest lobbying group said combining the No. 1 and No. 5 health insurers threatens to reduce competition in…
In an interview with The Rheumatologist, J. Larry Jameson, MD, PhD, discusses the benefits and complications of precision medicine for rheumatologists and their patients, including advances in genetics, diagnostic tools and targeted treatments…
Lisa Rapaport |
(Reuters Health)—A decades old Medicare rule requiring a three-day hospital stay before patients can transfer to skilled nursing facilities may needlessly prolong hospitalizations, a study suggests. Researchers compared the average time patients were hospitalized between 2006 and 2010 in privately administered Medicare Advantage health plans that either stuck to this rule or allowed people to…
Ransdell Pierson |
(Reuters)—Closer coordination between healthcare facilities and public health departments could save 37,000 U.S. lives over five years by preventing infections from antibiotic-resistant germs and from Clostridium difficile, according to a government report released on Tuesday. Germs that no longer respond to antibiotics cause more than 2 million illnesses and 23,000 deaths each year in the…
Phase 2 clinical trials have begun to assess the safety of brentuximab vedotin for the treatment of SLE. Also, the FDA is reviewing an application for a once-daily tofacitinib citrate tablet to treat RA…
Ben Hirschler |
LONDON (Reuters)—Drug industry productivity is continuing to improve, with a bumper haul of new products being launched and companies proving more successful in the final stages of clinical testing, according to a new analysis. Data from Thomson Reuters published on Tuesday showed the number of innovative medicines, or new molecular entities, launched globally in 2014…